Degradation of type II collagen, but not proteoglycan, correlates with matrix metalloproteinase activity in cartilage explant cultures
Open Access
- 1 January 1997
- journal article
- basic science
- Published by Wiley in Arthritis & Rheumatism
- Vol. 40 (1), 164-174
- https://doi.org/10.1002/art.1780400121
Abstract
Objective. To determine the contribution of certain matrix metalloproteinases (MMPs) to the degradation of proteoglycan and type II collagen in cartilage. Methods. Bovine nasal and articular cartilage explants were cultured with recombinant human interleukin-1α (IL-1α) for up to 4 weeks. Release of proteoglycan and type II collagen into the medium was determined by colorimetric assay and immunoassay, respectively. The activity of MMPs in the medium was assayed using a quenched fluorescent substrate, as well as with a collagen fibril assay, by zymography, and in Western immunoblots. In some experiments, the effects of specific MMP inhibitors on type II collagen degradation were studied. Results. In cultures of nasal cartilage with IL-1α, almost all the proteoglycan was released within the first week, whereas there was no detectable release of type II collagen for the first 2 weeks of culture. A rapid period of almost complete dissolution of the collagen occurred in the third or fourth week. MMP activity measured using a quenched fluorescent substrate was negligible during the first 2 weeks of culture but was substantially increased in the third week of culture, at the time of collagen degradation. Similarly, there was a large increase in collagenolytic activity (by collagen fibril assay) and gelatinolytic activity (by zymography) during the third week of culture. Articular cartilage cultured with IL-1α lost proteoglycan progressively during the 4-week period; however, there was no loss of type II collagen from the matrix in that time and no significant increase in MMP activity. The loss of type II collagen from nasal cartilage stimulated with IL-1α was inhibited by BB87, an inhibitor of both collagenases and gelatinases, and by BB3003, a selective inhibitor of gelatinase A. In Western immunoblots, procollagenase and active interstitial collagenase could be readily detected in nasal cartilage cultures. Some procollagenase 3 and active collagenase 3 was also shown to be present. Conclusion. MMP activity correlates with degradation of type II collagen, but not proteoglycan, in cartilage cultures. Interstitial collagenase, collagenase 3, and gelatinases are all likely to contribute to cleavage and removal of collagen from the cartilage matrix. The proteinase(s) responsible for aggrecan breakdown remains unclear.Keywords
This publication has 41 references indexed in Scilit:
- Effects of growth factors and interleukin-1 alpha on proteoglycan and type II collagen turnover in bovine nasal and articular chondrocyte pellet culturesEndocrinology, 1996
- Cloning, expression, and type II collagenolytic activity of matrix metalloproteinase-13 from human osteoarthritic cartilage.Journal of Clinical Investigation, 1996
- Interleukin-1 beta-modulated gene expression in immortalized human chondrocytes.Journal of Clinical Investigation, 1994
- Transcriptional suppression by interleukin‐1 and interferon‐γ of type II collagen gene expression in human chondrocytesJournal of Cellular Biochemistry, 1994
- Inhibition of cartilage proteoglycan release by a specific inactivator of cathepsin b and an inhibitor of matrix metalloproteinases. evidence for two converging pathways of chondrocyte‐mediated proteoglycan degradationArthritis & Rheumatism, 1993
- Preferential mRNA expression of prostromelysin relative to procollagenase and in situ localization in human articular cartilage.Journal of Clinical Investigation, 1992
- Differential regulation of metalloprotease steady‐state mRNA levels by IL‐1 and FGF in rabbit articular chondrocytesFEBS Letters, 1992
- A novel coumarin‐labelled peptide for sensitive continuous assays of the matrix metalloproteinasesFEBS Letters, 1992
- The origin of matrix metalloproteinases and their familial relationshipsFEBS Letters, 1991
- Human cartilage is degraded by rheumatoid arthritis synovial fluid but not by recombinant cytokines in vitroClinical and Experimental Immunology, 1991